Page last updated: 2024-10-22

alprazolam and Multiple Organ Failure

alprazolam has been researched along with Multiple Organ Failure in 1 studies

Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.

Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sin, JH1
Tom, A1
Toyoda, A1
Roy, N1
Hayes, BD1

Other Studies

1 other study available for alprazolam and Multiple Organ Failure

ArticleYear
High-dose intravenous lipid emulsion affecting successful initiation of continuous venovenous hemofiltration and extracorporeal membrane oxygenation.
    Clinical toxicology (Philadelphia, Pa.), 2018, Volume: 56, Issue:2

    Topics: Alprazolam; Antidotes; Digoxin; Diltiazem; Extracorporeal Membrane Oxygenation; Fat Emulsions, Intra

2018